Since last September, all of us on the staff of CRSToday have worked to fill each issue with clinical, practice, and business insights for dedicated cataract and refractive surgeons. We hope you have found our publication informative and enjoyable, and we encourage you to offer any suggestions you might have.
I would also like to offer three cheers of appreciation for the sensational efforts put forth by each and every contributor, many of whom submitted multiple lengthy and in-depth articles over the past year. Their continued hard work in the clinical setting, as well as their willingness to sacrifice their limited spare time to compose and review interesting articles, has furthered the understanding of the art and science of our field.
From my perspective as Chief Medical Editor, the finished product has been well worth our collective efforts. CRSToday continues to receive sensational feedback from practitioners and industry professionals alike. As we begin our second year, we intend to continue serving our primary audience: those progressive cataract and refractive surgeons who seek to improve with each new day. Foremost among our goals is assisting the ophthalmic community by providing an enhanced means of communication between surgeons. This consists of up-to-the-minute coverage of the ever-evolving issues and advancements that continue to reshape the field, complete with interactive multimedia presentations like the one you are receiving with this issue. We will keep bringing a fresh perspective to the study of ophthalmology, by means of open-debate formats, instructive articles, details on the latest technological developments, and timely updates on the medical-legal arena.
After 12 months of navigating the seas of the ophthalmic surgical field, I believe our ship remains on course. In the coming year, there are many exciting and uncharted ports of interest to which we will take our readers. That said, our success depends upon exceeding your expectations for an ophthalmic publication, and we encourage you to provide us with your clinical findings, questions, and advice.
See you onboard!
